🇧🇷 Promacta in Brazil

Promacta (ELTROMBOPAG) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Promacta in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Promacta approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Promacta in Brazil?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.